Last reviewed · How we verify
NCT03372720
Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors
NA trial testing Laser Therapy in Cervical Carcinoma in 19 participants. Completed in 12 April 2022.
18 December 2019
Quick facts
| Lead sponsor | Ohio State University Comprehensive Cancer Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 19 |
| Start date | 11 May 2018 |
| Primary completion | 18 December 2019 |
| Estimated completion | 12 April 2022 |
| Sites | 4 locations across United States |
Drugs / interventions tested
- Laser Therapy
- Questionnaire Administration
- Sham Intervention
Conditions studied
- Cervical Carcinoma — all drugs for Cervical Carcinoma →
- Dyspareunia — all drugs for Dyspareunia →
- Endometrial Carcinoma — all drugs for Endometrial Carcinoma →
- Ovarian Carcinoma — all drugs for Ovarian Carcinoma →
Sponsor
Ohio State University Comprehensive Cancer Center
Who can join
Eligibility, female only, with Cervical Carcinoma or Dyspareunia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This randomized pilot trial studies how well fractional carbon dioxide (CO2) laser therapy works in minimizing genitourinary syndrome of menopause (GSM) in gynecological cancer survivors. Fractional CO2 laser therapy may reduce symptoms of GSM in survivors of gynecologic cancers.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Pilot study of fractional CO<sub>2</sub> laser therapy for genitourinary syndrome of menopause in gynecologic cancer survivors.
Quick AM, Dockter T, Le-Rademacher J, Salani R, et al · · 2021 · cited 32× · PMID 33358206 · DOI 10.1016/j.maturitas.2020.10.018
Verify or expand the search:
- PubMed search for NCT03372720
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Laser Therapy
Trials testing the same drug.
- NCT07264153 — Laser Therapy in the Isotretinoin-Induced Sacroiliitis · NA · recruiting
- NCT07069153 — Laser vs Ozone Therapy for Oral Mucositis in Cancer Patients · NA · completed
- NCT05452668 — Laser Therapy Effect on Oral Mucositis in Childhood Acute Lymphoblastic Leukemia Patients · NA · unknown
- NCT05989217 — Conservative Therapies in the Treatment of Temporomandibular Disorders · NA · active not recruiting
- NCT06262763 — High-intensity Laser Therapy for Sacroiliac Joint Pain · NA · unknown
Other recruiting trials for Cervical Carcinoma
Currently open trials in the same condition.
- NCT07407647 — Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer · Phase 2 · recruiting
- NCT07285044 — The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Tr · Phase 2 · recruiting
- NCT07281430 — Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04) · NA · recruiting
- NCT06804135 — Systemic and Tumor Immune Response During Pelvic (Chemo)Radiation and/or Brachytherapy for Cervical Cancer · recruiting
- NCT07118176 — Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers · Phase 1 · recruiting
Other Ohio State University Comprehensive Cancer Center trials
Trials by the same sponsor.
- NCT06816979 — Lumbar Punctures for the Detection of ctDNA in the Cerebrospinal Fluid of Patients With Stage III and IV Non-Small Cell · NA · not yet recruiting
- NCT07529483 — Endoscopic Ultrasound-Guided Chemoablation for the Treatment of Pancreatic Cysts · Phase 2 · not yet recruiting
- NCT07455513 — A Novel Tobacco Cessation Resource for Smokers With a Diagnosed or Suspected Thoracic Cancer · NA · not yet recruiting
- NCT07217990 — Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer · Phase 1, PHASE2 · not yet recruiting
- NCT07503925 — THRIVE Study: Understanding How Oral Nicotine Pouches Affect Public Health · Phase 4 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03372720 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ohio State University Comprehensive Cancer Center
- Last refreshed: 22 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03372720.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing